Boston, USA (Sept. 14-15) / Virtual Day (Sept. 28)
Health Decisions, A Division of Premier Research, returns for the third year as an Associate Partner of the Women’s Health Innovation Summit. We are proud to support the sector’s leading platform committed to strengthening the network, tackling unmet needs, and championing innovative approaches and solutions for this critically underserved industry.
Women’s Health Case Study: Optimizing Study Enrollment During the Covid-19 Pandemic
Sept. 14, 12:10-12:45 p.m. EDT
A review of best practices for study design, site selection, patient engagement, and building a collaborative Sponsor-CRO partnership through the lens of a women’s health clinical trial that enrolled nearly twice as fast as anticipated despite launching just as the COVID-19 pandemic shut down most of the US.
- Dr. Mary Gunn, Chief Operating Officer, Health Decisions
- Sabrina Johnson, President & CEO, Dare Biosciences
- Jessica Hatheway, Clinical Operations, Health Decisions
Networking Drinks Hosted by Health Decisions
Sept. 14, 6-7 p.m. EDT